Compare TLPH & QXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLPH | QXL |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 75.6M |
| IPO Year | 2010 | 2015 |
| Metric | TLPH | QXL |
|---|---|---|
| Price | $1.19 | $4.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 299.9K | 64.1K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $2,151,000.00 | ★ $26,941,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $45.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.47 | $4.05 |
| 52 Week High | $1.57 | $7.70 |
| Indicator | TLPH | QXL |
|---|---|---|
| Relative Strength Index (RSI) | 42.96 | 42.60 |
| Support Level | $0.74 | $4.09 |
| Resistance Level | $1.48 | $5.29 |
| Average True Range (ATR) | 0.09 | 0.40 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 21.79 | 27.27 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Quantum X Labs Inc is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization of quantum technologies and intellectual property. The company operates across a broad range of domains, including quantum computing, quantum sensing, navigation systems, atomic clocks, and quantum algorithms, with applications spanning defense, aerospace, transportation, cybersecurity, and life sciences.